Publication
Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study.
Journal Paper/Review - Feb 15, 2012
De Marchis Gian Marco, Katan Mira, Weck Anja, Brekenfeld Caspar, Mattle Heinrich Paul, Buhl Daniela, Müller-Stich Beat P, Christ-Crain Mirjam, Arnold Marcel
Units
PubMed
Doi
Contact
Citation
De Marchis G, Katan M, Weck A, Brekenfeld C, Mattle H, Buhl D, Müller-Stich B, Christ-Crain M, Arnold M. Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study. Int J Stroke 2012; 8:214-8.
Type
Journal Paper/Review (English)
Journal
Int J Stroke 2012; 8
Publication Date
Feb 15, 2012
Issn Electronic
1747-4949
Pages
214-8
Brief description/objective
Copeptin independently predicts functional outcome and mortality at 90 days and one-year after ischemic stroke. In patients with transient ischemic attack, elevated copeptin values indicate an increased risk of further cerebrovascular events.